Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor
- Kamal Ahmed
- , Alexey Koval
- , Jiabin Xu
- , Alexandre Bodmer
- , Vladimir L. Katanaev*
*Corresponding author for this work
- University of Lausanne
- University of Geneva
- Far Eastern Federal University
Research output: Contribution to journal › Article › peer-review
57
Link opens in a new tab
Citations
(Scopus)